Ventas, Inc.
VTRReal Estate Reit Healthcare Facilities
Ventas, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, up 18.5% from fiscal 2024.
- Revenue
- +23.0%
- EPS
- −7.14%
- Free cash flow
- +20.5%
- Total debt
- −1.07%
Quarter to September 2026, against a year earlier
After hours trading: 86.55, down 0.02%, last trade 7:28pm Eastern.
Follow VTR
Alert me
Ventas, Inc. (VTR) P/S ratio
As of Nov 20, 2026, Ventas, Inc. (VTR) trades at a P/S ratio of 6.6×. Over the past ten years it has ranged from 1.6× (March 2020) to 10.1× (April 2015); the current reading is higher than 79% of that period. That is above the Reit Healthcare Facilities industry median of 5.2× and above the Real Estate sector median of 2.7×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 6.0× | 22.58% |
| FY2024 | 4.9× | 9.00% |
| FY2023 | 4.5× | 2.90% |
| FY2022 | 4.4× | (14.12%) |
| FY2021 | 5.1× | 5.96% |
| FY2020 | 4.8× | (11.59%) |
| FY2019 | 5.5× | (2.08%) |
| FY2018 | 5.6× | (6.20%) |
| FY2017 | 5.9× | (4.47%) |
| FY2016 | 6.2× | 9.65% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 6.4× | (4.51%) |
| Jun 2026 | 6.7× | 6.22% |
| Mar 2026 | 6.3× | 5.20% |
| Dec 2025 | 6.0× | 5.05% |
| 43 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| DOC Healthpeak Properties, Inc. compare | 4.3× |
| AHR American Healthcare REIT, Inc. compare | 4.7× |
| SBRA Sabra Healthcare REIT, Inc. compare | 5.7× |
| HR Healthcare Realty Trust Incorporated compare | 5.8× |
| VTR Ventas, Inc. | 6.6× |
| NHI National Health Investors, Inc. compare | 6.6× |
| OHI Omega Healthcare Investors, Inc. compare | 10.6× |
| WELL Welltower Inc. compare | 12.6× |
| CTRE CareTrust REIT, Inc. compare | 14.4× |
| Reit Healthcare Facilities industry median | 5.2× |
| Real Estate sector median | 2.7× |
| Market median | 1.7× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on VTR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- The full statement